Kangmei Pharma | 600518 - Cost Of Sales

Stock Price
1.57
Daily Change
-0.02 -1.26%
Monthly
-9.77%
Yearly
-21.11%
Q2 Forecast
1.59

Kangmei Pharma reported CNY1.11B in Cost of Sales for its fiscal quarter ending in September of 2025.





Cost Of Sales Change Date
Akebia Therapeutics USD 10.34M 441K Dec/2025
Alaunos Therapeutics USD 0 18K Sep/2024
Avita Medical AUD 3.3M 166K Dec/2025
Cspc Pharmaceutical CNY 2.11B 173.58M Dec/2025
Genomma Lab Internacional MXN 1.53B 34.69M Mar/2026
Hypermarcas BRL 858.94M 6.26M Dec/2025
Ionis Pharmaceuticals USD 3M 5M Mar/2026
IQVIA Holdings USD 3.08B 161M Mar/2026
Jiangsu Hengrui CNY 1.09B 76.27M Mar/2026
Kangmei Pharma CNY 1.11B 84.66M Sep/2025
Moderna USD 955M 503M Mar/2026
Organon & Co USD 766M 21M Dec/2025
Revvity USD 323.46M 26.93M Mar/2026
Sh Fosun Pharma CNY 5.07B 507.9M Mar/2026
Viatris USD 2.36B 195.9M Mar/2026
Wuxi Apptec CNY 6.17B 95.51M Mar/2026
Xeris Pharmaceuticals USD 13.66M 49K Dec/2025
Zz Pientze Pharmaceu CNY 1.58B 245.15M Mar/2026